In breast cancer cells, ETS1 and ESE1 reciprocally regulate the expression of ZEB1/2, and the net outcome is mainly dictated by ERK1/2 activity, which positively impacts on ETS1 transactivation of ZEB1/2, while it inhibits their transcriptional repression by ESE1.60 Here, MAPK3 is linked to breast cancer.